Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Neuroone Medical Technologies (NMTC) over the last 14 years, with Q4 2025 value amounting to -$3.1 million.

  • Neuroone Medical Technologies' Cash from Operations fell 159764.48% to -$3.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$6.2 million, marking a year-over-year increase of 1191.3%. This contributed to the annual value of -$2.8 million for FY2025, which is 7423.44% up from last year.
  • Per Neuroone Medical Technologies' latest filing, its Cash from Operations stood at -$3.1 million for Q4 2025, which was down 159764.48% from -$1.5 million recorded in Q3 2025.
  • In the past 5 years, Neuroone Medical Technologies' Cash from Operations registered a high of $1.0 million during Q3 2022, and its lowest value of -$3.8 million during Q4 2023.
  • For the 5-year period, Neuroone Medical Technologies' Cash from Operations averaged around -$2.2 million, with its median value being -$2.5 million (2021).
  • Per our database at Business Quant, Neuroone Medical Technologies' Cash from Operations surged by 15015.59% in 2022 and then plummeted by 159764.48% in 2025.
  • Neuroone Medical Technologies' Cash from Operations (Quarter) stood at -$2.7 million in 2021, then tumbled by 30.35% to -$3.5 million in 2022, then fell by 9.08% to -$3.8 million in 2023, then soared by 105.46% to $208049.0 in 2024, then tumbled by 1597.64% to -$3.1 million in 2025.
  • Its Cash from Operations was -$3.1 million in Q4 2025, compared to -$1.5 million in Q3 2025 and -$1.5 million in Q2 2025.